Instrument Inactif

Autres langues Monto Minerals Ltd Australian S.E.

Actions

AU000000MOO0

Equipement et technologie médicale avancés

Cours en clôture Australian S.E.
- ^AUD	-

31/08	Pathkey.AI Ltd publie ses résultats pour l'exercice clos le 30 juin 2026	CI
12/08	Pathkey.AI lève près de 3 millions de dollars australiens via un placement stratégique ; le titre bondit de 29 %	MT

Autres langues

31/08	Pathkey.AI Ltd Reports Earnings Results for the Full Year Ended June 30, 2026
12/08	Pathkey.AI Raises Nearly AU$3 Million Via Strategic Placement; Shares Up 29%
15/07	INTURAI SIGNS WITH ASX-LISTED PATHKEY TO ADVANCE DRONE SWARM COMMAND AND CONTROL ON AI EDGE
23/06	Pathkey.AI Ltd acquired Chipforge Pte Ltd for AUD 29.41 million.
11/05	Pathkey.AI appoints Andrew Farnsworth as CEO
29/04	Pathkey.AI to acquire AI semiconductor design verification platform
29/04	Pathkey.AI Ltd agreed to acquire Chipforge Pte Ltd for AUD 29.41 million
27/04	Pathkey.AI requests trading halt
13/03	Pathkey.Ai Ltd Advises That the Registered Office and Principal Place of Business Has Changed to Sydney NSW
26/02	Pathkey.AI Ltd Reports Earnings Results for the Half Year Ended December 31, 2025
27/11	Pathkey.AI says A$2.5 million placement successfully completed at A$0.012 per share
26/11	Pathkey.AI Ltd Announces Executive Changes
25/11	Pathkey.ai seeks trading halt
12/11	ASX Small-Cap Stocks to Watch
21/10/25	Pathkey.ai says Saurabh Jain steps down as executive chairman
21/10/25	Pathkey.AI Ltd Announces Board Changes, Effective October 21, 2025
22/09/25	Pathkey.AI Ltd Auditor Raises 'Going Concern' Doubt
18/09/25	Pathkey.AI Says Analytics Platform Analyzes 42 Clinical Trials in Proof-of-Concept Study, Shares Jump 17%
29/08/25	Pathkey.AI Ltd Reports Earnings Results for the Full Year Ended June 30, 2025
12/08/25	Opyl Executes Definitive Services Agreement with UK-Based Innovatrix Capital
12/08/25	Opyl Ltd signs services agreement with Innovatrix
26/06/25	Opyl Boosts Digital Innovation With Strategic Bitcoin Acquisition
18/06/25	Opyl Launches Clinical Trial Insurance Product in Partnership with UK Firm
17/06/25	Opyl Limited Appoints Matt Hallam as Chief Revenue Officer, Effective June 17, 2025
12/06/25	Opyl Signs Agreements With Netherlands-Based Cardialysis And UK-Based Evestia Clinical